A video shared online authentically showed an injured stray dog walking into a veterinarian's clinic and receiving treatment.

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...

Add Yahoo as a preferred source to see more of our stories on Google. Can dogs be used to detect cancer in other dogs? Researchers have found that it may be possible when it comes to hemangiosarcoma, ...

Researchers are engineering bacteria to invade tumors and consume them from the inside. Because tumor cores lack oxygen, they’re the perfect breeding ground for these microbes. The team added a ...

The term “brain tumor” carries a particularly scary connotation. And if you’re a fan of TV medical dramas, you may think they’re quite common. However, less than 1% of Americans are living with a ...

The National Comprehensive Cancer Network (NCCN) published new guidelines for pediatric soft tissue sarcoma (STS), growing the NCCN’s library of guidelines to now cover 91 topics in cancer care. 1 ...

Spontaneous regression of cancer is an uncommon event observed most often in neuroblastoma, leukemia, lung cancer, and melanoma. The underlying mechanisms are not fully understood; however, infections ...

The epidemiology of tumor lysis syndrome is evolving with the introduction of newer therapies. The occurrence of tumor lysis syndrome has become a less predictable but increasingly important aspect of ...

“US healthcare utilization for IH continued to rise between 2009 and 2019, corresponding to a growing number of cases, increased awareness, timely diagnosis, and more effective treatments for IH,” ...

Two canine osteosarcoma patients who underwent amputations are shown in 2023, when their care team and owners celebrated their final chemo treatments by ringing a bell and giving both dogs lots of ...

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer Safety and Tolerability of ...

VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...